B. Gaillac

发表

Despite financial penalties, French physicians' knowledge of regulatory practice guidelines is poor.

P. Ravaud, B. Giraudeau, P. Durieux, 2000, Archives of family medicine.

Expanding indication of padeliporfin (WST11) vascular-targeted photodynamic therapy: Results of prostate cancer Latin-American multicenter study

L. Reis, B. Gaillac, F. Benzaghou, 2018, Actas Urológicas Españolas (English Edition).

A Randomised Clinical Trial in Men with Low-risk Prostate Cancer

C. Stief, G. Salomon, F. Kleinclauss, 2017 .

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11‐vascular‐targeted photodynamic (VTP) therapy

J. Trachtenberg, A. Villers, C. Moore, 2015, BJU international.

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Antonio Alcaraz, Jens Rassweiler, Christian Gratzke, 2017, The Lancet. Oncology.

Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).

C. Stief, B. Gaillac, C. Stief, 2019, European urology focus.

Radical prostatectomy after vascular targeted photodynamic therapy Tookad® Soluble: Feasability, short and long term results

G. Salomon, F. Kleinclauss, S. Joniau, 2017 .

Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results

H. G. van der Poel, G. Salomon, M. Emberton, 2019, The Journal of urology.

Radical prostatectomy after vascular-targeted photodynamic therapy (VTP) with TOOKAD® : feasibility, early and intermediate results

M. Emberton, F. Kleinclauss, J. Rassweiler, 2018 .

Expanding indication of padeliporfin (WST11) vascular-targeted photodynamic therapy: results of prostate cancer Latin-American multicenter study.

B. Gaillac, F. Benzaghou, P. Palma, 2018, Actas urologicas espanolas.